Skip to main content

Welcome to the CRL Insurer Services blog. From big data and insurtech to accelerated underwriting and self-service products, the world of life insurance is moving at an unprecedented pace. We are confident that mortality data and insurance industry capabilities will continue to evolve, and seek to provide relevant expertise and updates to our valued clients.

As we continue to provide lab, data, and underwriting services through the CRL Insurers Business Unit, we look forward to sharing updates with you here. Check out the latest posts below from our dedicated team of medical directors and industry leaders, who provide commentary on timely topics, innovative services and solutions, and the existing database of CRL expertise.

 

COVID-19 Antibody Prevelance Increased throughout 2020: New Research from CRL

January 7, 2021

Dr. Robert Stout, Co-Founder and Chief Scientific Officer at CRL, and Dr. Steven Rigatti, Consulting Medical Director with CRL, conducted… Read More

Tags: Coronavirus, Covid 19, Covid 19 Crisis, Life Insurance, Risk Management

CRL Receives FDA Emergency Use Authorization for Best-in-Class Self-Collected COVID-19 Saliva Test

August 3, 2020

CRL has received FDA Emergency Use Authorization (EUA) and is scaling up capacity for CRL Rapid Responseā„¢, a saliva-based COVID-19… Read More

Tags: Coronavirus, Covid 19, Covid 19 Crisis, Covid 19 Testing, FDA

COVID-19 Research Updates & Resources: April 22

April 22, 2020

As COVID-19 continues to be top of mind, we are committed to serving our customers and understanding the virus. There… Read More

Tags: Coronavirus, Covid 19, Covid 19 Crisis, Laboratory, Molecular Diagnostics